• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KNTC1 knockdown 通过 MCM2 抑制骨肉瘤细胞的增殖和迁移。

KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.

机构信息

Department of Orthopedics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.

Department of Radiology, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.

出版信息

Mol Carcinog. 2024 Aug;63(8):1599-1610. doi: 10.1002/mc.23748. Epub 2024 May 31.

DOI:10.1002/mc.23748
PMID:38818892
Abstract

Osteosarcoma (OS) is a common primary malignant bone tumor, and it is necessary to further investigate the molecular mechanism of OS progression. The expression of kinetochore associated protein 1 (KNTC1) and minichromosome maintenance 2 (MCM2) was detected by immunohistochemistry, quantitative PCR (qPCR) and Western blot. Gene knockdown or overexpression cell models were constructed and the proliferation, apoptosis, cell cycle and migration were detected in vitro, besides, xenograft models were established to explore the effects of KNTC1 downregulation in vivo. Public databased and bioinformatics analysis were performed to screen the downstream molecules and determine the expression of MCM2 in cancers. KNTC1 was overexpressed in OS tissues and positively correlated with overall survival of OS patients. KNTC1 knockdown inhibited the proliferation and migration, and arrested G2 phase, and induced apoptosis. Besides, KNTC1 downregulation restricted the xenograft tumor formation. MCM2, one of the coexpressed genes, was highly expressed in sarcoma and downregulated after KNTC1 knockdown. MCM2 overexpression heightened the proliferation and migration ability of OS cells, which was reversed the inhibiting effects of KNTC1 knockdown. KNTC1 was overexpressed in OS and promoted the progression of OS by upregulating MCM2.

摘要

骨肉瘤(OS)是一种常见的原发性恶性骨肿瘤,有必要进一步研究 OS 进展的分子机制。通过免疫组织化学、定量 PCR(qPCR)和 Western blot 检测着丝粒相关蛋白 1(KNTC1)和微小染色体维持蛋白 2(MCM2)的表达。构建基因敲低或过表达细胞模型,检测体外增殖、凋亡、细胞周期和迁移,此外,还建立了异种移植模型以体内研究 KNTC1 下调的作用。进行了公共数据库和生物信息学分析以筛选下游分子并确定 MCM2 在癌症中的表达。KNTC1 在 OS 组织中过表达,并与 OS 患者的总生存率呈正相关。KNTC1 敲低抑制增殖和迁移,使 G2 期停滞,并诱导凋亡。此外,KNTC1 下调限制了异种移植肿瘤的形成。MCM2 是共表达基因之一,在肉瘤中高表达,并且在 KNTC1 敲低后表达下调。MCM2 过表达增强了 OS 细胞的增殖和迁移能力,这逆转了 KNTC1 敲低的抑制作用。KNTC1 在 OS 中过表达,通过上调 MCM2 促进 OS 的进展。

相似文献

1
KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2.KNTC1 knockdown 通过 MCM2 抑制骨肉瘤细胞的增殖和迁移。
Mol Carcinog. 2024 Aug;63(8):1599-1610. doi: 10.1002/mc.23748. Epub 2024 May 31.
2
Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.微小染色体维持蛋白2和3通过DHX9促进骨肉瘤进展并预示患者预后不良。
Oncotarget. 2017 Apr 18;8(16):26380-26393. doi: 10.18632/oncotarget.15474.
3
Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.敲低 lncRNA GHET1 抑制骨肉瘤细胞在体外和体内的增殖、侵袭、迁移和 EMT。
Cancer Biomark. 2018;23(4):589-601. doi: 10.3233/CBM-181863.
4
Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.长链非编码 RNA SBF2-AS1 的沉默通过上调 microRNA-30a 抑制 FOXA1 表达,抑制骨肉瘤细胞的增殖、迁移和侵袭并促进细胞凋亡。
Cell Cycle. 2019 Oct;18(20):2727-2741. doi: 10.1080/15384101.2019.1656478. Epub 2019 Aug 21.
5
Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma.miRNA-154-5p 的上调可预防骨肉瘤的发生。
Biomed Pharmacother. 2020 Apr;124:109884. doi: 10.1016/j.biopha.2020.109884. Epub 2020 Jan 27.
6
Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.MALAT1基因敲低通过调控miR-34a/细胞周期蛋白D1轴抑制骨肉瘤进展。
Int J Oncol. 2019 Jan;54(1):17-28. doi: 10.3892/ijo.2018.4600. Epub 2018 Oct 19.
7
Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.长链非编码 RNA HOXD-AS1 敲低抑制骨肉瘤的进展。
Biomed Pharmacother. 2018 Feb;98:899-906. doi: 10.1016/j.biopha.2018.01.024. Epub 2018 Jan 8.
8
Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.长链非编码RNA TUG1通过吸附miR-132-3p并上调SOX4表达促进骨肉瘤细胞增殖并抑制其凋亡。
Yonsei Med J. 2018 Mar;59(2):226-235. doi: 10.3349/ymj.2018.59.2.226.
9
miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling.MALAT1 调控的 miR-485-3p 通过直接抑制 c-MET 和 AKT3/mTOR 信号通路抑制骨肉瘤糖酵解和转移。
Life Sci. 2021 Mar 1;268:118925. doi: 10.1016/j.lfs.2020.118925. Epub 2021 Jan 7.
10
MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.miR-363 通过与 NOB1 结合抑制骨肉瘤细胞迁移、侵袭和上皮-间充质转化。
World J Surg Oncol. 2020 May 1;18(1):83. doi: 10.1186/s12957-020-01859-y.